BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mpabanzi L, Jalan R. Neurological complications of acute liver failure: pathophysiological basis of current management and emerging therapies. Neurochem Int. 2012;60:736-742. [PMID: 22100567 DOI: 10.1016/j.neuint.2011.10.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Pruitt AA, Graus F, Rosenfeld MR. Neurological complications of solid organ transplantation. Neurohospitalist 2013;3:152-66. [PMID: 24167649 DOI: 10.1177/1941874412466090] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
2 Bosoi CR, Rose CF. Brain edema in acute liver failure and chronic liver disease: similarities and differences. Neurochem Int 2013;62:446-57. [PMID: 23376027 DOI: 10.1016/j.neuint.2013.01.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
3 Li Y, Zhang J, Xu P, Sun B, Zhong Z, Liu C, Ling Z, Chen Y, Shu N, Zhao K, Liu L, Liu X. Acute liver failure impairs function and expression of breast cancer-resistant protein (BCRP) at rat blood-brain barrier partly via ammonia-ROS-ERK1/2 activation. J Neurochem 2016;138:282-94. [DOI: 10.1111/jnc.13666] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
4 Ommati MM, Jamshidzadeh A, Niknahad H, Mohammadi H, Sabouri S, Heidari R, Abdoli N. N-acetylcysteine treatment blunts liver failure-associated impairment of locomotor activity. PharmaNutrition 2017;5:141-7. [DOI: 10.1016/j.phanu.2017.10.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
5 Fan Y, Liu X. Alterations in Expression and Function of ABC Family Transporters at Blood-Brain Barrier under Liver Failure and Their Clinical Significances. Pharmaceutics 2018;10:E102. [PMID: 30041501 DOI: 10.3390/pharmaceutics10030102] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Zhang YB, Liu ZK, Chen LM, Yuan YS, Ji ZW, Li JG. Assessment of cognitive function of patients after resolution of overt hepatic encephalopathy with ice cap participated treatment. Shijie Huaren Xiaohua Zazhi 2014; 22(5): 679-684 [DOI: 10.11569/wcjd.v22.i5.679] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Kulstad EB, Naiman M, Shanley P, Garrett F, Haryu T, Waller D, Azarafrooz F, Courtney DM. Temperature modulation with an esophageal heat transfer device - a pediatric swine model study. BMC Anesthesiol 2015;15:16. [PMID: 25685058 DOI: 10.1186/1471-2253-15-16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Seetharam A. Intensive Care Management of Acute Liver Failure: Considerations While Awaiting Liver Transplantation. J Clin Transl Hepatol 2019;7:384-91. [PMID: 31915608 DOI: 10.14218/JCTH.2019.00032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Stravitz RT, Gottfried M, Durkalski V, Fontana RJ, Hanje AJ, Koch D, Hameed B, Ganger D, Subramanian RM, Bukofzer S, Ravis WR, Clasen K, Sherker A, Little L, Lee WM; Acute Liver Failure Study Group. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia. Hepatology 2018;67:1003-13. [PMID: 29080224 DOI: 10.1002/hep.29621] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
10 Frozandeh F, Shahrokhi N, Khaksari M, Amiresmaili S, AsadiKaram G, Shahrokhi N, Iranpour M. Evaluation of the protective effect of curcumin on encephalopathy caused by intrahepatic and extrahepatic damage in male rats. Iran J Basic Med Sci 2021;24:760-6. [PMID: 34630953 DOI: 10.22038/ijbms.2021.53171.11976] [Reference Citation Analysis]
11 Michinaga S, Koyama Y. Pathogenesis of brain edema and investigation into anti-edema drugs. Int J Mol Sci 2015;16:9949-75. [PMID: 25941935 DOI: 10.3390/ijms16059949] [Cited by in Crossref: 125] [Cited by in F6Publishing: 102] [Article Influence: 17.9] [Reference Citation Analysis]
12 Hori T, Uemoto S, Walden LB, Chen F, Baine AM, Hata T, Kogure T, Nguyen JH. Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice. Hepatol Res 2014;44:651-62. [PMID: 23672352 DOI: 10.1111/hepr.12161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
13 Weingarten MA, Sande AA. Acute liver failure in dogs and cats. J Vet Emerg Crit Care (San Antonio) 2015;25:455-73. [PMID: 25882813 DOI: 10.1111/vec.12304] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]